Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes: can an improvement in infection control practices decrease MRSA prevalence?
| ISRCTN | ISRCTN79334890 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN79334890 |
| Secondary identifying numbers | EAT/2953/04 |
- Submission date
- 06/06/2006
- Registration date
- 19/06/2006
- Last edited
- 04/01/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Michael Tunney
Scientific
Scientific
Queen's University Belfast
School of Pharmacy
Medical Biology Centre
97 Lisburn Road
Belfast
BT9 7BL
United Kingdom
| m.tunney@qub.ac.uk |
Study information
| Study design | Phase 1 is observational; Phase 2 is a cluster randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Prevention |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | |
| Study objectives | 1. What is the prevalence of MRSA in nursing homes in the Northern Health and Social Services Board? 2. Can an improvement in infection control standards result in a decrease in MRSA prevalence in nursing homes in this board area? |
| Ethics approval(s) | Ethical approval granted by the Office for Research Ethics Committees Northern Ireland (ORECNI) on 03/11/2005, reference number: 05/NIR03/154 |
| Health condition(s) or problem(s) studied | Methicillin-resistant Staphyloccus aureus (MRSA) colonisation |
| Intervention | Nasal and skin swab and urinary catheter sample where appropriate from residents in both phases 1 and 2. In phase 2, homes assigned to the intervention group will receive an audit of current infection control practices followed by infection control training and feedback. In control homes, routine care will continue as normal. |
| Intervention type | Other |
| Primary outcome measure | In phase 1, determination of MRSA prevalence in nursing homes in Northern Health and Social Services (NHSSB). In phase 2, the prevalence of MRSA in intervention homes compared to control homes following infection control intervention, audit and feedback. |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/11/2005 |
| Completion date | 01/11/2008 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Senior |
| Sex | Both |
| Target number of participants | All 66 nursing homes in NHSSB |
| Key inclusion criteria | Phase 1: all nursing homes in the Northern Board will be asked to participate. Within these homes, all residents and staff will be invited to participate. Phase 2: For a nursing home to be considered in this phase, it must have at least 20 consenting adults. |
| Key exclusion criteria | Nursing home residents who are terminally ill, in a coma or not deemed fit to personally give consent and have no next-of-kin available to give consent, will be excluded from both phases of the trial. For staff, there are no specific exclusion criteria, other than failure to provide written informed consent. |
| Date of first enrolment | 01/11/2005 |
| Date of final enrolment | 01/11/2008 |
Locations
Countries of recruitment
- Northern Ireland
- United Kingdom
Study participating centre
Queen's University Belfast
Belfast
BT9 7BL
United Kingdom
BT9 7BL
United Kingdom
Sponsor information
Queens University Belfast (UK)
University/education
University/education
Lanyon Building
University Road
Belfast
BT7 1NN
Northern Ireland
United Kingdom
| Phone | +44 (0) 289 027 2568 |
|---|---|
| d.weir@qub.ac.uk | |
"ROR" |
https://ror.org/00hswnk62 |
Funders
Funder type
Government
Central Services Agency, a part of the Northern Ireland Health and Social Services (NIHSS), Reasearch and Development Office (EAT/2953/04)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/09/2010 | Yes | No |
